Trinity Street Asset Management LLP Charles River Laboratories International, Inc. Transaction History

Trinity Street Asset Management LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 22, 2021	SELL	$222.0 - $252.62 $44 Million - $50.1 Million	-198,226 Closed	0 $0
Q3 2020 Oct 20, 2020	SELL	$175.56 - $226.45 $8.54 Million - $11 Million	-48,649 Reduced 19.71%	198,226 $44.9 Million
Q2 2020 Jul 28, 2020	BUY	$118.84 - $189.72 $939,073 - $1.5 Million	7,902 Added 3.31%	246,875 $43 Million
Q1 2020 Apr 22, 2020	BUY	$98.9 - $178.34 $4.56 Million - $8.22 Million	46,104 Added 23.9%	238,973 $30.2 Million
Q4 2019 Jan 14, 2020	BUY	$126.05 - $152.76 $894,198 - $1.08 Million	7,094 Added 3.82%	192,869 $29.5 Million
Q3 2019 Oct 23, 2019	BUY	$125.07 - $143.67 $5.18 Million - $5.95 Million	41,400 Added 28.68%	185,775 $24.6 Million
Q2 2019 Jul 18, 2019	BUY	$123.4 - $148.55 $17.8 Million - $21.4 Million	144,375 New	144,375 $20.5 Million

703

52.8M

157K

413K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $7.73B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Trinity Street Asset Management LLP, based on Form 13F filings with the SEC.

Stay updated on Trinity Street Asset Management LLP with notifications on news.